Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin for the Prolongation of Pregnancy in Preterm Preeclampsia

NCT06452498 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.

NCT NCT06452498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06452498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin for the Prolongation of Pregnancy in Preterm Preeclampsia
Lead sponsor
Amsterdam UMC
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 31, 2024
Completion date
July 31, 2028
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hellp, hellp syndrome, hellp syndrome complicating pregnancy, pre-eclampsia, pre-eclampsia as antepartum condition, pre-eclampsia onset less than 37 weeks, pre-eclampsia or eclampsia with pre-existing hypertension, pre-eclampsia; affecting fetus, pre-eclampsia; complicating pregnancy